Revenio Group Corporation: REVENIO'S BOARD OF DIRECTORS

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Revenio Group Corporation: REVENIO'S BOARD OF DIRECTORS CONFIRMS THE COMPANY'S DISCLOSURE POLICY

Revenio Group Corporation   Stock Exchange Release       4 August 2014 at 9:05 hrs REVENIO'S BOARD OF DIRECTORS CONFIRMS THE COMPANY'S DISCLOSURE POLICY Revenio Group Corporation's Board of Directors has confirmed Revenio's disclosure policy whose key objective is to ensure that all operators in the market have an access to simultaneously sufficient and accurate information on the company and its business operations to establish the price formation of securities issued by the company. The most important change from the company's previous practice is the harmonization of the quiet period and the closed window so that both now begin 14 days prior to the publication of interim reports and 21 days prior to the publication of financial statements. The disclosure policy is available in full on the company website at http://www.reveniogroup.fi/en/investor-communications/ Revenio Group Corporation Olli-Pekka Salovaara President & CEO For additional information, please contact President & CEO Olli-Pekka Salovaara, tel. +358 40 567 5520 olli-pekka.salovaara@revenio.fi DISTRIBUTION: NASDAQ OMX Helsinki Financial Supervisory Authority (FIN-FSA) Principal media www.revenio.fi The Revenio Group in brief Revenio is a Finnish health tech group whose core business is tonometers. The Revenio Health Tech segment comprises the business operations of Icare Finland Oy. The widely patented Icare product family is the current cornerstone of the Group's success. Revenio seeks vigorous growth in health technology, both organically and through acquisitions and mergers. The Revenio Group also includes other business operations, which are grouped under the Technology and Services segment. This segment's operations have a shared global market and represent the cutting edge of technology products and services in their industry. These businesses generate positive cash flow for the Group. In 2013, the Revenio Group's net sales totaled EUR 25.7 million, with its operating margin standing at 21.7 %. The Revenio Group Corporation is listed on NASDAQ OMX Helsinki. [HUG#1845722]

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Exploring Innovative Nonprofit Incubation Strategies by NVF

Updated Category News Views 252

Exploring Innovative Nonprofit Incubation Strategies by NVF Today, New Venture Fund has brought forth a significant report highlighting the nonprofit incubation process, titled "Growing Change: How New Venture Fund Incubates Nonprofits to Make Lasting Impact." This report sheds light on the intricacies of incubation, showcasing the essential characteristics of successful...

Continue Reading
Julio Herrera Velutini Exonerated in Major Legal Battle

Updated Category News Views 439

Resolution of Legal Matters for Julio Herrera Velutini Following extensive and rigorous legal proceedings, Venezuelan-British banker, Julio Herrera Velutini, experienced a significant and favorable resolution in his legal case. This outcome follows more than three years of intense scrutiny regarding allegations against him, specifically targeting serious criminal charges....

Continue Reading
The Rise of Height-Adjustable Desks by 2029: What You Need to Know

Updated Category News Views 124

Growth Perspective on Height-Adjustable Desks The market for contemporary height-adjustable desks has been thriving, reflecting an expected increase of USD 2.75 billion by 2029. This surge is significantly driven by the growing demand for modern desks that promote better ergonomics in both office and home environments. This trend is part of a larger movement towards...

Continue Reading
Barnwell Industries Faces 52-Week Low: A Turning Point

Updated Category News Views 57

Barnwell Industries Inc Stock Performance Review Barnwell Industries Inc (BRN) has recently encountered a challenging period, highlighted by its stock touching a 52-week low at $1.99. This significant decrease in stock value is alarming for investors and stakeholders alike. Over the past year, Barnwell's share price has plummeted by 21.48%, a clear indication of bearish...

Continue Reading
Exploring Advanced Oncology Solutions at Altogen Labs

Updated Category News Views 214

Innovative Approaches to Oncology at Altogen Labs Altogen Labs stands out as a premier preclinical research organization focused on propelling the field of oncology forward. They dedicate themselves to the innovative testing and evaluation of new treatments. With an emphasis on pharmacological and biological therapies, Altogen Labs aims to deliver groundbreaking...

Continue Reading